Wintest
6721
Showcase
3909
Beauty Kadan Holdings
3041
Cybozu
4776
KODAMA CHEMICAL INDUSTRY
4222
(FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | (Q1)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 38.82%94.27B | -7.92%41.02B | 222.42%14.42B | 94.19%23.17B | 125.08%15.66B | -0.73%67.91B | 97.18%44.55B | -82.71%4.47B | -24.21%11.93B | 65.81%6.96B |
Cost of revenue | 35.75%64.54B | -13.14%27.41B | 200.91%10.88B | 115.02%15.8B | 108.18%10.44B | -8.51%47.54B | 73.84%31.56B | -81.13%3.62B | -36.41%7.35B | 62.53%5.01B |
Gross profit | 45.96%29.73B | 4.74%13.6B | 313.80%3.54B | 60.77%7.37B | 168.59%5.22B | 23.86%20.37B | 192.70%12.99B | -87.26%855M | 9.51%4.58B | 74.91%1.95B |
Operating expense | 15.18%6.91B | 58.05%2.38B | 45.46%1.57B | -29.82%1.55B | 16.79%1.41B | 18.03%6B | 15.25%1.5B | -13.53%1.08B | 63.55%2.2B | 2.54%1.21B |
Operating profit | 58.81%22.82B | -2.24%11.23B | 974.22%1.97B | 144.70%5.82B | 417.93%3.81B | 26.47%14.37B | 266.63%11.48B | -104.12%-225M | -16.15%2.38B | 1,198.51%736M |
Net non-operating interest income (expenses) | -64.88%-859M | 0.56%-176M | -188.39%-323M | -65.25%-195M | -44.74%-165M | 3.87%-521M | -82.47%-177M | 38.46%-112M | 9.23%-118M | 14.29%-114M |
Non-operating interest income | 200.00%33M | 425.00%21M | 66.67%5M | 100.00%4M | 50.00%3M | -74.42%11M | -73.33%4M | -62.50%3M | -81.82%2M | -77.78%2M |
Non-operating interest expense | 30.26%594M | 50.91%166M | 49.56%169M | 22.88%145M | -0.87%114M | -12.81%456M | -0.90%110M | -16.91%113M | -15.11%118M | -16.06%115M |
Total other finance cost | 292.11%298M | -56.34%31M | 7,850.00%159M | 2,600.00%54M | 5,300.00%54M | 22.58%76M | 7,000.00%71M | -96.30%2M | 0.00%2M | -80.00%1M |
Net investment income | 90.58%263M | 1,737.50%147M | 22.89%-128M | -23.96%73M | -14.50%171M | -8.00%138M | -92.52%8M | -166M | 96M | 20,100.00%200M |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | -182M | 0 | ||||||||
Income from associates and other participating interests | ||||||||||
Special income (charges) | -227.79%-4.64B | -299.57%-4.68B | -1,260.00%-58M | 152.26%127M | -425.00%-21M | -115.88%-1.41B | -96.31%-1.17B | 400.00%5M | -417.02%-243M | 66.67%-4M |
Less:Restructuring and mergern&acquisition | --3.05B | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Less:Other special charges | -174.22%-190M | --0 | --0 | ---- | ---- | 401.96%256M | 300.00%14M | -400.00%-5M | 417.02%243M | -66.67%4M |
Less:Write off | 53.37%1.78B | 41.11%1.63B | --58M | --63M | --21M | 91.72%1.16B | --1.16B | --0 | --0 | --0 |
Other non-operating income (expenses) | -660.00%-112M | -645.45%-60M | -5,900.00%-60M | 0 | -57.89%8M | -74.03%20M | -42.11%11M | -104.35%-1M | -145.00%-9M | 26.67%19M |
Income before tax | 37.35%17.3B | -38.25%6.27B | 380.72%1.4B | 176.99%5.83B | 354.72%3.81B | 21.06%12.59B | 295.94%10.15B | -109.31%-498M | -21.85%2.1B | 520.60%837M |
Income tax | 37.59%5.78B | -50.96%1.79B | 458.86%567M | 452.52%2.08B | 303.61%1.34B | 11.23%4.2B | 276.68%3.65B | -108.25%-158M | -62.67%377M | 381.36%332M |
Net income | 37.23%11.52B | -31.10%4.48B | 344.84%830M | 116.86%3.74B | 389.09%2.47B | 26.67%8.39B | 307.65%6.5B | -109.88%-339M | 2.74%1.73B | 722.22%504M |
Net income continuous operations | 37.23%11.52B | -31.11%4.48B | 344.41%831M | 116.80%3.74B | 388.32%2.47B | 26.67%8.39B | 307.65%6.5B | -109.91%-340M | 2.68%1.73B | 723.46%505M |
Noncontrolling interests | -68.75%5M | 800.00%14M | -131.25%-5M | -6M | 0.00%2M | 433.33%16M | -300.00%-2M | 16M | 0 | 2M |
Net income attributable to the company | 37.45%11.51B | -31.33%4.47B | 331.30%835M | 116.85%3.75B | 387.55%2.47B | 26.33%8.38B | 307.26%6.5B | -110.51%-361M | 2.80%1.73B | 724.69%506M |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | 37.45%11.51B | -31.33%4.47B | 331.30%835M | 116.85%3.75B | 387.55%2.47B | 26.33%8.38B | 307.26%6.5B | -110.51%-361M | 2.80%1.73B | 724.69%506M |
Gross dividend payment | ||||||||||
Basic earnings per share | 50.63%406.28 | -25.80%156.52 | 516.33%32.89 | 147.24%130.59 | 522.96%86.28 | 49.04%269.72 | 383.39%210.95 | -108.43%-7.9 | 15.20%52.82 | 726.70%13.85 |
Diluted earnings per share | 50.63%406.28 | -26.24%155.6008 | 330.49%29.0914 | 147.02%130.4748 | 522.96%86.28 | 49.04%269.72 | 383.48%210.95 | -113.47%-12.6216 | 15.24%52.82 | 726.70%13.85 |
Dividend per share | 218.18%175 | 218.18%175 | 0 | 0 | 0 | 48.65%55 | 48.65%55 | 0 | 0 | 0 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |